Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...
Leads Biolabs is developing LBL-047, a new bispecific antibody for autoimmune diseases that targets B cells and pDCs. LBL-047 ...
The IQ debate has placed Gen Z and millennials side by side. Millennials grew up with limited technology and relied more on ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果